Methods For The Identification, Assessment, And Treatment Of Patients With Proteasome Inhibition Therapy

Patent No. EP1581629 (titled "Methods For The Identification, Assessment, And Treatment Of Patients With Proteasome Inhibition Therapy") was filed by Millennium Pharmaceuticals on Dec 4, 2003. The application was issued on Apr 1, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SKYLINEDXDec 29, 2015VO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1581629

MILLENNIUM PHARMACEUTICALS
Application Number
EP03796633A
Filing Date
Dec 4, 2003
Status
Revoked
Apr 15, 2019
Publication Date
Apr 1, 2015